Table 1. Patient Characteristics.
Variables | Groups | n | % |
---|---|---|---|
Sex | Male | 34 | 62 |
Female | 21 | 38 | |
Age (yrs) | Median (range) | 54 (24-81) | |
≥60 | 17 | 32 | |
<60 | 38 | 68 | |
Ann Arbor stage | I | 39 | 71 |
II | 16 | 29 | |
Performance status | ECOG 0, 1 | 52 | 94 |
ECOG 2 | 3 | 6 | |
Primary site | Sinonasal | 47 | 86 |
Others | 8 | 14 | |
Epstein-Barr virus | Yes | 13 | 24 |
Not checked | 42 | 76 | |
Serum LDH | Elevated | 26 | 68 |
Normal | 12 | 32 | |
B symptoms | Yes | 13 | 24 |
No | 42 | 76 | |
IPI | 1 (low) | 21 | 38 |
2 (low intermediate) | 28 | 51 | |
3 (high-intermediate) | 6 | 11 | |
4 (high) | 0 | 0 | |
NKPI | Group 1 | 19 | 35 |
Group 2 | 21 | 38 | |
Group 3 | 13 | 24 | |
Group 4 | 2 | 4 |
ECOG, Eastern Cooperative Oncology Group; IPI, international prognostic index; LDH, lactate dehydrogenase; NKPI, NK/T cell lymphoma prognostic index. 6